EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Modeling Patterns of Medication Adherence in Primary Open-Angle Glaucoma

Shervonne Poleon, Michael Twa, Yu-Mei Schoenberger-Godwin, Mathew Fifolt, Lyne Racette

Ophthalmology Science · 2025-07 · 5 (4) · 100706

DOI: 10.1016/j.xops.2025.100706 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ophthalmology Science, 2025-07. Verfasst von Shervonne Poleon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Optometry and Vision Science, School of Optometry, University of Alabama at Birmingham, Birmingham, Alabama. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NEI NIH HHS, Foundation for the National Institutes of Health, Research to Prevent Blindness.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To use group-based trajectory modeling to identify patterns of medication adherence in patients with primary open-angle glaucoma (POAG) and to identify factors associated with each pattern.

Design

Prospective cohort study.

Participants

Seventy-two patients with POAG who were enrolled in a National Institutes of Health-funded progression study at the University of Alabama at Birmingham were included in this study. Patients were required to be >18 years of age, have a diagnosis of POAG, and be prescribed hypotensive eye drops to treat their glaucoma.

Methods

Fifty-two weeks of mean weekly medication adherence data were collected using Medication Event Monitoring Systems. Group-based trajectory modeling was used to estimate models with 2, 3, 4, 5, and 6 medication adherence trajectory groups. Self-reported race and illness perception were included as covariates. The model with the lowest Bayesian information criterion (which provides a measure of the trade-off between model fit and model complexity) and the highest number of clinically relevant trajectory groups was deemed optimal. Main Outcome Measures: Medication adherence trajectory groups.

Results

The Bayesian information criterion was -1041.1 for the 2-group model, -755.9 for the 3-group model, -643.8 for the 4-group model, -590.4 for the 5-group model, and -559.0 for the 6-group model. We identified the 4-group model as the most optimal. The 4 trajectory groups estimated by this model were near-perfect adherence (51.8% of participants), good adherence (23.2% of participants), declining adherence (18.1% of participants), and poor adherence (6.9% of participants). Compared with the poor adherence group, a higher illness perception score predicted a lower probability of membership in the good (B = -0.276, P = 0.042) and declining (B = -0.303, P = 0.028) adherence groups.

Conclusions

Medication adherence is an important clinical outcome that is associated with disease severity and disease progression in POAG. Further investigation of this important topic may reveal other shared clinical characteristics that can be used to identify patients who may be at risk for adverse clinical outcomes such as glaucoma progression. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Schlagwörter

Stichwörter der Autor:innen

GBTMGlaucomaMedication adherenceModeling

Autor:innen und Institutionen

  • Department of Optometry and Vision Science, School of Optometry, University of Alabama at Birmingham, Birmingham, Alabama.
  • Department of Ophthalmology and Visual Sciences, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
  • University of Houston College of Optometry, Houston, Texas.
  • Division of Preventive Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
  • Department of Health Care Organization and Policy, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama.

Förderung

  • NEI NIH HHS
  • Foundation for the National Institutes of Health
  • Research to Prevent Blindness
  • National Institutes of Health

Zitieren

APA

Poleon, S., Twa, M., Schoenberger-Godwin, Y. M., Fifolt, M., & Racette, L. (2025). Modeling Patterns of Medication Adherence in Primary Open-Angle Glaucoma. Ophthalmology Science, 5(4), 100706. https://doi.org/10.1016/j.xops.2025.100706

Vancouver

Poleon S, Twa M, Schoenberger-Godwin YM, Fifolt M, Racette L. Modeling Patterns of Medication Adherence in Primary Open-Angle Glaucoma. Ophthalmology Science. 2025;5(4):100706. doi:10.1016/j.xops.2025.100706

BibTeX
@article{Poleon2025,
  author = {Poleon, Shervonne and Twa, Michael and Schoenberger-Godwin, Yu-Mei and Fifolt, Mathew and Racette, Lyne},
  title = {Modeling Patterns of Medication Adherence in Primary Open-Angle Glaucoma},
  journal = {Ophthalmology Science},
  year = {2025},
  volume = {5},
  number = {4},
  pages = {100706},
  doi = {10.1016/j.xops.2025.100706}
}
Kostenlos starten →